The global peripheral vascular stent market is projected to expand from USD 4.59 billion in 2025 to USD 9.55 billion by 2035, reflecting a compound annual growth rate (CAGR) of 7.6%. The market’s steady rise is being fueled by a sharp increase in peripheral artery disease (PAD), driven by aging populations, diabetes prevalence, and lifestyle-related cardiovascular risks.
Peripheral vascular stents have become indispensable in minimally invasive vascular procedures, offering enhanced vessel patency and reduced restenosis rates. Their expanding use in lower extremity revascularization and critical limb ischemia management is transforming the treatment landscape for PAD patients worldwide.
Market Overview
- Market Size (2025): USD 4.59 billion
- Forecast Value (2035): USD 9.55 billion
- CAGR (2025–2035): 7.6%
- Top-Selling Product Type: Self-expanding stents (53.1% share, 2025)
- Leading Artery Segment: Iliac artery (48% share, 2025)
- Fastest-Growing End User: Ambulatory surgical centers (7.9% CAGR)
- Top Growth Markets: China (10.3% CAGR), GCC (7.6%), India (7.1%)
Get exclusive access to detailed market statistics and trends — request your free sample report today!
Technology and Treatment Innovation Driving Growth
Recent years have seen a wave of innovation reshaping vascular interventions. Manufacturers are focusing on drug-eluting and bioresorbable stents designed to improve long-term vascular outcomes and minimize complications. These devices release therapeutic agents that prevent neointimal hyperplasia, improving vessel patency and patient recovery.
Next-generation stents now feature ultra-thin struts, flexible designs, and advanced polymer coatings, providing superior deliverability and fracture resistance. Bioabsorbable scaffolds and AI-assisted stent placement tools are further enhancing precision and reducing procedural time.
As personalized medicine advances, companies are introducing patient-specific stent designs that account for arterial geometry and disease progression, offering tailored care for complex PAD cases.
Segment Insights: Drug-Eluting and Self-Expanding Stents Lead
Drug-eluting stents (DES) are experiencing rapid adoption as they combine mechanical support with localized drug delivery. Backed by strong clinical data, DES devices have shown superior outcomes in femoral-popliteal (fem-pop) and below-the-knee interventions, especially in elderly and diabetic populations.
Meanwhile, self-expanding stents remain the volume leaders due to their adaptability to peripheral vessel anatomy and resilience in tortuous vascular regions. Balloon-expandable stents retain a niche role for iliac interventions requiring precision and high radial strength, while covered stents remain essential for aneurysm repair and vessel perforation cases.
End-User Trends: Outpatient Procedures on the Rise
The global shift toward ambulatory surgical centers (ASCs) is reshaping the peripheral stent landscape. ASCs are projected to grow at a 7.9% CAGR, driven by their cost efficiency and shorter patient recovery times. Improved device technology now enables same-day discharge for many PAD interventions, expanding patient access to minimally invasive care.
Hospitals, however, continue to dominate total procedural volume due to their advanced imaging suites and multidisciplinary vascular teams, especially for complex or emergency interventions.
Regional Outlook
- United States (5.9% CAGR): The U.S. remains the world’s largest peripheral stent market, driven by early FDA approvals of new DES systems and a strong ecosystem of vascular specialists.
- United Kingdom (6.4% CAGR): Ongoing clinical trials, such as BD’s AGILITY study, are expanding PAD treatment options and accelerating adoption of next-gen covered stents.
- China (10.3% CAGR): A rapidly aging population and government-backed innovation in medical devices are spurring domestic stent production and affordability.
- India (7.1% CAGR): Expanding elderly populations, affordable angioplasty options, and innovations like Concept Medical’s MagicTouch sirolimus-coated balloon are boosting treatment uptake.
- GCC Countries (7.6% CAGR): Public awareness campaigns and investment in high-end vascular devices are improving early PAD diagnosis and treatment access.
Competitive Landscape
The market is led by Medtronic Plc., Abbott Laboratories, Boston Scientific Corporation, B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Stryker, and Terumo. These companies are accelerating research into drug-polymer combinations and bioabsorbable materials to expand their product portfolios.
Notable developments include:
- Becton, Dickinson and Company (BD) launching a vascular stent study under its AGILITY program.
- Biotronik’s Orsiro DES gaining approval in China, enhancing access to next-generation stents.
- Sahajanand Medical Technologies (SMT) acquiring a Brazilian distribution firm to expand into Latin America’s fast-growing interventional cardiology market.
Collaborations between device manufacturers and research institutions are fostering the creation of AI-guided stenting solutions and 4D-printed vascular scaffolds, underscoring the sector’s technological shift toward precision and sustainability.
Future Outlook
As global awareness of PAD grows and healthcare systems emphasize value-based care, peripheral vascular stents are set to play a central role in reducing amputations, improving mobility, and extending life expectancy.
With robust innovation pipelines and emerging market expansion, the industry’s next decade will be defined by smarter, safer, and more patient-centric vascular solutions.
Purchase Full Report for Detailed Insights
For access to full forecasts, regional breakouts, company share analysis, and emerging trend assessments, you can purchase the complete report here: Buy Full Report – Peripheral Vascular Stent Market
Have a specific Requirements and Need Assistant on Report Pricing or Limited Budget please contact us – [email protected]
About Future Market Insights (FMI)
Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted by Fortune 500 clients and global enterprises. With operations in the U.S., UK, India, and Dubai, FMI provides data-backed insights and strategic intelligence across 30+ industries and 1200 markets worldwide.
